Search

SUVEXX Assay Out of Specification Recall - Lot 0000159323

Health Canada has issued a Type III recall for SUVEXX tablets (DIN 02496305, containing Sumatriptan 85mg and Naproxen sodium 500mg), lot 0000159323, distributed nationally in Canada. The recall was initiated after the assay was found to be out of specification in the affected lot. Aralez Pharmaceuticals Canada Inc. issued the recall with a depth covering retailers. Patients and healthcare providers are advised to verify if their product is affected and to consult a healthcare provider before discontinuing use.